BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4664004)

  • 1. [STH blood level after metopirone in 12 patients with acromegaly].
    Chiodini PG; Liuzzi A; Spinelli F; Botalla L; Silvestrini F
    Ann Endocrinol (Paris); 1972; 33(4):431-5. PubMed ID: 4664004
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of medroxyprogesterone acetate (MPA) on the blood level of STH in 12 patients with acromegaly].
    Liuzzi A; Chiodini PG; Botalla L; Silvestrini F
    Ann Endocrinol (Paris); 1972; 33(4):426-30. PubMed ID: 4664003
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of TRF, propranolol-glucagon, insulin and glucose stimulation tests in acromegaly.
    Coutant G; Vandeweghe M; Vermeulen A
    Horm Metab Res; 1977 Jan; 9(1):17-21. PubMed ID: 403115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorpromazine treatment and growth hormone secretory responses in acromegaly.
    Dimond RC; Bramer SR; Atkinson RL; Howard WJ; Earll JM
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1189-95. PubMed ID: 4706207
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dynamic investigations of pituitary function in patients with chromophobe pituitary adenoma or with acromegaly].
    Muhlbauer MA; Ruedi B; Lemarchand-Beraud T; Buber B; Aubert M; Felber JP
    Ann Endocrinol (Paris); 1972; 33(4):440-6. PubMed ID: 4351896
    [No Abstract]   [Full Text] [Related]  

  • 6. Variable response of plasma GH in acromegalic patients treated with medroxyprogesterone acetate.
    Malarkey WB; Daughaday WH
    J Clin Endocrinol Metab; 1971 Sep; 33(3):424-31. PubMed ID: 4936883
    [No Abstract]   [Full Text] [Related]  

  • 7. Secretin and insulin release in acromegaly.
    Chisholm DJ; Lazarus L; Young JD
    J Clin Endocrinol Metab; 1972 Jul; 35(1):108-12. PubMed ID: 5032508
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Ferrari C; Travaglini P; Ambrosi B; Spada A
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1259-62. PubMed ID: 4196265
    [No Abstract]   [Full Text] [Related]  

  • 9. [Growth hormone: interpretation of the test results].
    Kato Y; Imura H
    Nihon Rinsho; 1969 Mar; ():Suppl:958-68. PubMed ID: 4948305
    [No Abstract]   [Full Text] [Related]  

  • 10. Cryohypophysectomy for acromegaly. Factors associated with altered endocrine function and carbohydrate metabolism.
    Levin SR; Hofeldt FD; Schneider V; Becker N; Karam JH; Seymour RJ; Adams JE; Forsham PH
    Am J Med; 1974 Oct; 57(4):526-35. PubMed ID: 4432860
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison between various stimulation tests used for the study of somatotropic function in children].
    Donnadieu M; Combourieu M; Schimpff RM
    Pathol Biol (Paris); 1971 Mar; 19(5):293-301. PubMed ID: 4929992
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum growth hormone and prolactin response to thyrotropin-releasing hormone in patients with acromegaly before and after surgery.
    Samaan NA; Leavens ME; Jesse RH
    J Clin Endocrinol Metab; 1974 Jun; 38(6):957-63. PubMed ID: 4208807
    [No Abstract]   [Full Text] [Related]  

  • 13. [Permanent and non-suppressable somatotropic hypersecretion in acromegaly].
    Strauch G; Modigliani E; Bricaire H
    Presse Med (1893); 1970 Jan; 78(4):167-70. PubMed ID: 4907364
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of beneficial response of serum GH in acromegalic patients treated with medroxyprogesterone acetate (MPA).
    Jackson IM; Ormston BJ
    J Clin Endocrinol Metab; 1972 Sep; 35(3):413-5. PubMed ID: 5051364
    [No Abstract]   [Full Text] [Related]  

  • 15. Serial assays of plasma growth hormone in treated and untreated acromegaly.
    Hunter WM; Gillingham FJ; Harris P; Kanis JA; McGurk FM; McLelland J; Strong JA
    J Endocrinol; 1974 Oct; 63(1):21-34. PubMed ID: 4417605
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses.
    Liuzzi A; Chiodini PG; Botalla L; Silvestrini F; Müller EE
    J Clin Endocrinol Metab; 1974 Nov; 39(5):871-6. PubMed ID: 4214404
    [No Abstract]   [Full Text] [Related]  

  • 17. [Radioimmunoassay of human growth hormone].
    Irie M; Sakuma M
    Nihon Naibunpi Gakkai Zasshi; 1966 Aug; 42(5):475-88. PubMed ID: 6007896
    [No Abstract]   [Full Text] [Related]  

  • 18. [Secretion of growth hormone and ACTH in pituitary tumors].
    Materazzi F; Rolla M; Tronchetti F
    Ann Endocrinol (Paris); 1972; 33(4):344-52. PubMed ID: 4351893
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum-insulin in acromegaly.
    Elkeles RS; Wright AD; Lowy C; Fraser TR
    Lancet; 1969 Sep; 2(7621):615-8. PubMed ID: 4185594
    [No Abstract]   [Full Text] [Related]  

  • 20. [Somatotrophic response to hypoglycemic stimulus in patients with acromegaly. Effect of bromocriptine].
    Fiszlejder L; Bokser L; Puyo AM; Chervin AB; Guitelman A
    Medicina (B Aires); 1986; 46(1):16-24. PubMed ID: 3543606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.